Cargando…

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

AIMS/HYPOTHESIS: Type 2 diabetes increases the risk of cardiovascular and renal complications, but early risk prediction could lead to timely intervention and better outcomes. Genetic information can be used to enable early detection of risk. METHODS: We developed a multi-polygenic risk score (multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Johanne, Haloui, Mounsif, Attaoua, Redha, Tahir, Ramzan, Hishmih, Camil, Harvey, François, Marois-Blanchet, François-Christophe, Long, Carole, Simon, Paul, Santucci, Lara, Hizel, Candan, Chalmers, John, Marre, Michel, Harrap, Stephen, Cífková, Renata, Krajčoviechová, Alena, Matthews, David R., Williams, Bryan, Poulter, Neil, Zoungas, Sophia, Colagiuri, Stephen, Mancia, Giuseppe, Grobbee, Diederick E., Rodgers, Anthony, Liu, Liusheng, Agbessi, Mawussé, Bruat, Vanessa, Favé, Marie-Julie, Harwood, Michelle P., Awadalla, Philip, Woodward, Mark, Hussin, Julie G., Hamet, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382653/
https://www.ncbi.nlm.nih.gov/pubmed/34226943
http://dx.doi.org/10.1007/s00125-021-05491-7
_version_ 1783741578693574656
author Tremblay, Johanne
Haloui, Mounsif
Attaoua, Redha
Tahir, Ramzan
Hishmih, Camil
Harvey, François
Marois-Blanchet, François-Christophe
Long, Carole
Simon, Paul
Santucci, Lara
Hizel, Candan
Chalmers, John
Marre, Michel
Harrap, Stephen
Cífková, Renata
Krajčoviechová, Alena
Matthews, David R.
Williams, Bryan
Poulter, Neil
Zoungas, Sophia
Colagiuri, Stephen
Mancia, Giuseppe
Grobbee, Diederick E.
Rodgers, Anthony
Liu, Liusheng
Agbessi, Mawussé
Bruat, Vanessa
Favé, Marie-Julie
Harwood, Michelle P.
Awadalla, Philip
Woodward, Mark
Hussin, Julie G.
Hamet, Pavel
author_facet Tremblay, Johanne
Haloui, Mounsif
Attaoua, Redha
Tahir, Ramzan
Hishmih, Camil
Harvey, François
Marois-Blanchet, François-Christophe
Long, Carole
Simon, Paul
Santucci, Lara
Hizel, Candan
Chalmers, John
Marre, Michel
Harrap, Stephen
Cífková, Renata
Krajčoviechová, Alena
Matthews, David R.
Williams, Bryan
Poulter, Neil
Zoungas, Sophia
Colagiuri, Stephen
Mancia, Giuseppe
Grobbee, Diederick E.
Rodgers, Anthony
Liu, Liusheng
Agbessi, Mawussé
Bruat, Vanessa
Favé, Marie-Julie
Harwood, Michelle P.
Awadalla, Philip
Woodward, Mark
Hussin, Julie G.
Hamet, Pavel
author_sort Tremblay, Johanne
collection PubMed
description AIMS/HYPOTHESIS: Type 2 diabetes increases the risk of cardiovascular and renal complications, but early risk prediction could lead to timely intervention and better outcomes. Genetic information can be used to enable early detection of risk. METHODS: We developed a multi-polygenic risk score (multiPRS) that combines ten weighted PRSs (10 wPRS) composed of 598 SNPs associated with main risk factors and outcomes of type 2 diabetes, derived from summary statistics data of genome-wide association studies. The 10 wPRS, first principal component of ethnicity, sex, age at onset and diabetes duration were included into one logistic regression model to predict micro- and macrovascular outcomes in 4098 participants in the ADVANCE study and 17,604 individuals with type 2 diabetes in the UK Biobank study. RESULTS: The model showed a similar predictive performance for cardiovascular and renal complications in different cohorts. It identified the top 30% of ADVANCE participants with a mean of 3.1-fold increased risk of major micro- and macrovascular events (p = 6.3 × 10(−21) and p = 9.6 × 10(−31), respectively) and a 4.4-fold (p = 6.8 × 10(−33)) higher risk of cardiovascular death. While in ADVANCE overall, combined intensive blood pressure and glucose control decreased cardiovascular death by 24%, the model identified a high-risk group in whom it decreased the mortality rate by 47%, and a low-risk group in whom it had no discernible effect. High-risk individuals had the greatest absolute risk reduction with a number needed to treat of 12 to prevent one cardiovascular death over 5 years. CONCLUSIONS/INTERPRETATION: This novel multiPRS model stratified individuals with type 2 diabetes according to risk of complications and helped to target earlier those who would receive greater benefit from intensive therapy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05491-7.
format Online
Article
Text
id pubmed-8382653
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83826532021-09-15 Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control Tremblay, Johanne Haloui, Mounsif Attaoua, Redha Tahir, Ramzan Hishmih, Camil Harvey, François Marois-Blanchet, François-Christophe Long, Carole Simon, Paul Santucci, Lara Hizel, Candan Chalmers, John Marre, Michel Harrap, Stephen Cífková, Renata Krajčoviechová, Alena Matthews, David R. Williams, Bryan Poulter, Neil Zoungas, Sophia Colagiuri, Stephen Mancia, Giuseppe Grobbee, Diederick E. Rodgers, Anthony Liu, Liusheng Agbessi, Mawussé Bruat, Vanessa Favé, Marie-Julie Harwood, Michelle P. Awadalla, Philip Woodward, Mark Hussin, Julie G. Hamet, Pavel Diabetologia Article AIMS/HYPOTHESIS: Type 2 diabetes increases the risk of cardiovascular and renal complications, but early risk prediction could lead to timely intervention and better outcomes. Genetic information can be used to enable early detection of risk. METHODS: We developed a multi-polygenic risk score (multiPRS) that combines ten weighted PRSs (10 wPRS) composed of 598 SNPs associated with main risk factors and outcomes of type 2 diabetes, derived from summary statistics data of genome-wide association studies. The 10 wPRS, first principal component of ethnicity, sex, age at onset and diabetes duration were included into one logistic regression model to predict micro- and macrovascular outcomes in 4098 participants in the ADVANCE study and 17,604 individuals with type 2 diabetes in the UK Biobank study. RESULTS: The model showed a similar predictive performance for cardiovascular and renal complications in different cohorts. It identified the top 30% of ADVANCE participants with a mean of 3.1-fold increased risk of major micro- and macrovascular events (p = 6.3 × 10(−21) and p = 9.6 × 10(−31), respectively) and a 4.4-fold (p = 6.8 × 10(−33)) higher risk of cardiovascular death. While in ADVANCE overall, combined intensive blood pressure and glucose control decreased cardiovascular death by 24%, the model identified a high-risk group in whom it decreased the mortality rate by 47%, and a low-risk group in whom it had no discernible effect. High-risk individuals had the greatest absolute risk reduction with a number needed to treat of 12 to prevent one cardiovascular death over 5 years. CONCLUSIONS/INTERPRETATION: This novel multiPRS model stratified individuals with type 2 diabetes according to risk of complications and helped to target earlier those who would receive greater benefit from intensive therapy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05491-7. Springer Berlin Heidelberg 2021-07-06 2021 /pmc/articles/PMC8382653/ /pubmed/34226943 http://dx.doi.org/10.1007/s00125-021-05491-7 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tremblay, Johanne
Haloui, Mounsif
Attaoua, Redha
Tahir, Ramzan
Hishmih, Camil
Harvey, François
Marois-Blanchet, François-Christophe
Long, Carole
Simon, Paul
Santucci, Lara
Hizel, Candan
Chalmers, John
Marre, Michel
Harrap, Stephen
Cífková, Renata
Krajčoviechová, Alena
Matthews, David R.
Williams, Bryan
Poulter, Neil
Zoungas, Sophia
Colagiuri, Stephen
Mancia, Giuseppe
Grobbee, Diederick E.
Rodgers, Anthony
Liu, Liusheng
Agbessi, Mawussé
Bruat, Vanessa
Favé, Marie-Julie
Harwood, Michelle P.
Awadalla, Philip
Woodward, Mark
Hussin, Julie G.
Hamet, Pavel
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
title Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
title_full Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
title_fullStr Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
title_full_unstemmed Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
title_short Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
title_sort polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382653/
https://www.ncbi.nlm.nih.gov/pubmed/34226943
http://dx.doi.org/10.1007/s00125-021-05491-7
work_keys_str_mv AT tremblayjohanne polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT halouimounsif polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT attaouaredha polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT tahirramzan polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT hishmihcamil polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT harveyfrancois polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT maroisblanchetfrancoischristophe polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT longcarole polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT simonpaul polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT santuccilara polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT hizelcandan polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT chalmersjohn polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT marremichel polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT harrapstephen polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT cifkovarenata polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT krajcoviechovaalena polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT matthewsdavidr polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT williamsbryan polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT poulterneil polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT zoungassophia polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT colagiuristephen polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT manciagiuseppe polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT grobbeediedericke polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT rodgersanthony polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT liuliusheng polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT agbessimawusse polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT bruatvanessa polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT favemariejulie polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT harwoodmichellep polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT awadallaphilip polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT woodwardmark polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT hussinjulieg polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol
AT hametpavel polygenicriskscorespredictdiabetescomplicationsandtheirresponsetointensivebloodpressureandglucosecontrol